文章摘要
Xiaoyun Huang,Yan Si,Jia Zhao,Qiang Ding.[J].南京医科大学学报,2008,28(5):295~298
The evaluation of Tracp5b as a marker for monitoring treatment results of bone metastasis in breast cancer patients
投稿时间:2008-06-04  
DOI:10.7655
中文关键词: 
英文关键词: breast neoplasm  bone metastasis  tartrate-resistant acid phosphatase 5b  bisphosphonate  carcinoembryonic antigen  carbohydrate antigen 153
基金项目:
作者单位
Xiaoyun Huang Department of Breast Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China 
Yan Si  
Jia Zhao  
Qiang Ding  
摘要点击次数: 1012
全文下载次数: 1276
中文摘要:
      
英文摘要:
      Objective:To evaluate the sensitivity of serum tartrate-resistant acid phosphatase 5b(Tracp5b) activity in monitoring bisphosphonate treatment results of bone metastasis in breast cancer(BC) patients. Methods:The serum activities of Tracp5b, CEA, CA153 were mea-sured in 58 BC patients, including 26 without bone metastasis, 32 with bone metastasis. The serum activities of Tracp5b, CEA, CA153 were also measured in 19 patients with bone metastasis after 3 months of bisphosphonate treatment. Eighteen healthy women with age from 34 to 70 served as control. Results:Serum Tracp5b was significantly elevated in patients with bone metastasis compared with that in all any other groups(P < 0.05). The sensitivity of Tracp5b was 78.13% and the specificity was 86.36%. The sensitivity of CA153 was 37.50% and the specificity was 77.27%. The sensitivity of CEA was 21.88% and the specificity was 84.09%. The serum activity of Tracp5b decreased significantly(P < 0.05) after 3 months of bisphosphonate treatment, while the levels of CA153 and CEA were unchanged. Conclusion:Serum Tracp5b activity is a useful diagnostic marker for bone metastasis in BC patients and can be used to evaluate the treatment results of bisphosphonate.
查看全文   查看/发表评论  下载PDF阅读器
关闭